News about Market

Aptar Acquires Sommaplast, Provider of Oral Dosing Pharma Packaging Solutions

The acquisition of Sommaplast strengthens Aptar’s pharmaceutical portfolio and expands its footprint in Latin America, giving the company access to Sommaplast’s established expertise in oral dosing components and its growing customer base across Brazil’s healthcare market.

Market | 04/12/2025 | By Dineshwori |  229

Philips Unveils World's First Helium-free 3.0T MRI Platform

Philips has introduced the world’s first helium-free 3.0T MRI platform, the BlueSeal Horizon, marking a significant technological milestone in medical imaging. The new system combines a fully sealed, helium-independent magnet with advanced AI tools to deliver faster workflows, improved sustainability, and enhanced clinical insights.

Market | 04/12/2025 | By Dineshwori |  483

Syntegon Makes Spare Parts Sourcing Easier with Mysyntegon Webshop

Syntegon has introduced a new digital platform, the mySyntegon webshop, designed to simplify machine spare-parts sourcing and ordering through AI-driven image recognition.

Market | 04/12/2025 | By Dineshwori |  211

Cipla Partners with Stempeutics, Launches Stem Cell Therapy for Knee Osteoarthritis

Cipla has partnered with Stempeutics to launch Ciplostem, a single-dose stem cell therapy for knee osteoarthritis. The treatment uses 25 million expanded Bone Marrow–derived Mesenchymal Stem Cells (BM-MSCs) combined with hyaluronic acid to support joint repair and pain relief.

Market | 04/12/2025 | By Dineshwori |  323

Sun Pharma Announces Major INR 3,000 Crore Expansion in MP

Sun Pharmaceutical Industries’ wholly owned subsidiary, Sun Pharma Laboratories Ltd, has approved an investment of INR 3,000 crore to set up a new greenfield formulations manufacturing facility in Madhya Pradesh.

Market | 04/12/2025 | By Darshana |  773

Where Will Pharma Investments Head Next?

As India’s pharma sector shifts from a volume-driven generics model to an innovation-led ecosystem, its investment landscape is rapidly transforming. Ambitions to become a global innovation hub are pushing companies to rethink capital allocation, with R&D, manufacturing diversification, and digital transformation emerging as priorities.

Market | 03/12/2025 | By Akanki |  646

Roche Secures FDA CLIA Waiver and CE Mark for Bordetella POC Test

Roche has received CE Mark approval for its first point-of-care test capable of diagnosing and differentiating Bordetella infections, including whooping cough, within 15 minutes. The rapid, PCR-accurate test enables faster clinical decisions and supports early intervention, particularly for vulnerable groups such as infants and the elderly.

Market | 03/12/2025 | By Dineshwori |  339

Lilly Lowers Zepbound's Single-dose Vials' Cost

Lilly has reduced the price of its Zepbound (tirzepatide) single-dose vials, reinforcing its commitment to improving affordability and expanding access for people living with obesity.

Market | 02/12/2025 | By Dineshwori |  402

Biocon Biologics Reaches Settlement with Amgen, Secures Market Entry Date for Denosumab Biosimilars

Biocon Biologics will introduce both its Denosumab biosimilars — Vevzuo and Evfraxy — in Europe beginning December 2, 2025. Other terms of the settlement with Amgen remain confidential.

Market | 02/12/2025 | By Dineshwori |  186

Sun Pharma Introduces ILUMYA in India for Plaque Psoriasis Treatment

Sun Pharma has launched its global innovative drug, ILUMYA (Tildrakizumab), in India for the treatment of moderate-to-severe plaque psoriasis.

Market | 01/12/2025 | By Dineshwori |  255